Clinical trialNCT01838499TerminatedPhase 2Interventional

Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa

SponsorAstraZenecaEnrollment224Hidradenitis Suppurativa

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to gain initial evidence for the safety, tolerability and efficacy of MEDI8968 for the treatment of subjects with moderate to severe hidradenitis suppurativa

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Robert AK Lee, MD
University of California, San Diego
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Phoenix, Arizona, United States
Research Site
Bakersfield, California, United States
Research Site
Fremont, California, United States
Research Site
Los Angeles, California, United States
Research Site
San Diego, California, United States
Research Site
San Francisco, California, United States
Research Site
Miami, Florida, United States
Research Site
Orange Park, Florida, United States
Research Site
Ormond Beach, Florida, United States
Research Site
Tampa, Florida, United States
Research Site
Atlanta, Georgia, United States
Research Site
Macon, Georgia, United States
Research Site
Skokie, Illinois, United States
Research Site
West Dundee, Illinois, United States
Research Site
Evansville, Indiana, United States
Research Site
Indianapolis, Indiana, United States
Research Site
Rockville, Maryland, United States
Research Site
St Louis, Missouri, United States
Research Site
Forest Hills, New York, United States
Research Site
Chapel Hill, North Carolina, United States
Research Site
High Point, North Carolina, United States
Research Site
Winston-Salem, North Carolina, United States
Research Site
Hershey, Pennsylvania, United States
Research Site
Philadelphia, Pennsylvania, United States
Research Site
Rapid City, South Dakota, United States
Research Site
Arlington, Texas, United States
Research Site
Norfolk, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

MEDI8968Saline

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 May 2013
Primary completion: 31 Oct 2014
Completion: 31 Oct 2014
Last update posted: 1 Sept 2016
Registered enrollment: 224
Registry id: NCT01838499

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.